Vilazodone hydrochloride - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for vilazodone hydrochloride and what is the scope of patent protection?

Vilazodone hydrochloride is the generic ingredient in two branded drugs marketed by Abbvie, Accord Hlthcare, Alembic, Apotex, Invagen Pharms, and Teva Pharms Usa, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for vilazodone hydrochloride. Fourteen suppliers are listed for this compound.

Summary for vilazodone hydrochloride

US Patents:	0
Tradenames:	2
Applicants:	6
NDAs:	6
Drug Master File Entries:	12
Finished Product Suppliers / Packagers:	14
Raw Ingredient (Bulk) Api Vendors:	85
Clinical Trials:	27
Patent Applications:	162
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for vilazodone hydrochloride
What excipients (inactive ingredients) are in vilazodone hydrochloride?	vilazodone hydrochloride excipients list
DailyMed Link:	vilazodone hydrochloride at DailyMed

Recent Clinical Trials for vilazodone hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
CGStat LLC
University of New Mexico
National Alliance on Mental Illness Westside Los Angeles

See all vilazodone hydrochloride clinical trials

Medical Subject Heading (MeSH) Categories for vilazodone hydrochloride

Antidepressive Agents
Serotonin 5-HT1 Receptor Agonists
Serotonin Uptake Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for vilazodone hydrochloride

N06AX	Other antidepressants
N06A	ANTIDEPRESSANTS
N06	PSYCHOANALEPTICS
N	Nervous system

Paragraph IV (Patent) Challenges for VILAZODONE HYDROCHLORIDE

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
VIIBRYD	Tablets	vilazodone hydrochloride	10 mg, 20 mg, and 40 mg	022567	5	2015-01-21

US Patents and Regulatory Information for vilazodone hydrochloride

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Invagen Pharms	VILAZODONE HYDROCHLORIDE	vilazodone hydrochloride	TABLET;ORAL	208200-003	Dec 6, 2022	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva Pharms Usa	VILAZODONE HYDROCHLORIDE	vilazodone hydrochloride	TABLET;ORAL	208212-001	Sep 30, 2019	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Alembic	VILAZODONE HYDROCHLORIDE	vilazodone hydrochloride	TABLET;ORAL	208202-003	Jan 10, 2020	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for vilazodone hydrochloride

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbvie	VIIBRYD	vilazodone hydrochloride	TABLET;ORAL	022567-001	Jan 21, 2011	⤷ Sign Up	⤷ Sign Up
Abbvie	VIIBRYD	vilazodone hydrochloride	TABLET;ORAL	022567-003	Jan 21, 2011	⤷ Sign Up	⤷ Sign Up
Abbvie	VIIBRYD	vilazodone hydrochloride	TABLET;ORAL	022567-002	Jan 21, 2011	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.